Buprenorphine is available under several brand names, primarily used for treating opioid use disorder and moderate to severe pain. These brands include:
What are the main buprenorphine brands for opioid use disorder?
For opioid use disorder (OUD), buprenorphine is most commonly found in formulations that combine it with naloxone. The primary brand for this combination is Suboxone [1]. Other brands that contain buprenorphine and naloxone include Zubsolv [2] and Cassipa [3]. Buprenorphine alone is also available as a sublingual tablet under the brand name Subutex [4].
Are there buprenorphine brands for pain relief?
Yes, buprenorphine is also prescribed for pain management. Brands for pain relief include the transdermal patch formulations Butrans [5] and Buprenex [6]. Buprenex is also available as an injection [6].
What is the difference between Suboxone and Subutex?
Suboxone contains both buprenorphine and naloxone. The naloxone is included to deter misuse of the buprenorphine; if Suboxone is injected, the naloxone will trigger withdrawal symptoms. Subutex contains buprenorphine alone and is typically prescribed during the initial phase of treatment for OUD under medical supervision to manage withdrawal symptoms, before transitioning to a combination product like Suboxone [4].
When do buprenorphine patents expire?
Patent expiry dates are crucial for determining when generic versions of a drug can enter the market. Information on specific patent expiries for buprenorphine products can be found on specialized patent tracking websites. For instance, DrugPatentWatch.com tracks patent information for pharmaceutical products, including buprenorphine [7]. The expiry of patents for various buprenorphine formulations and combinations will pave the way for generic competition.
Who manufactures these buprenorphine brands?
The manufacturers vary depending on the specific brand. For example, Suboxone is manufactured by Indivior [1], while Zubsolv is made by Orexo [2]. Reckitt Benckiser Pharmaceuticals previously manufactured Suboxone and Subutex, but manufacturing and marketing rights have shifted [1, 4]. Butrans is manufactured by its parent company, Purdue Pharma [5].
What are the different forms of buprenorphine available?
Buprenorphine is available in several dosage forms:
* Sublingual films and tablets: These dissolve under the tongue and are used for OUD treatment (e.g., Suboxone, Subutex, Zubsolv) [1, 2, 4].
* Transdermal patches: These are applied to the skin for continuous pain relief (e.g., Butrans, Buprenex) [5, 6].
* Injections: Available for pain management (e.g., Buprenex) [6].
* Buccal films: Dissolve in the cheek [8].
How do buprenorphine brands compare in terms of effectiveness and side effects?
While buprenorphine itself is the active ingredient, different brand formulations and delivery methods may influence patient experience. For OUD, combination products like Suboxone and Zubsolv are designed to treat cravings and withdrawal symptoms while deterring misuse due to the naloxone component [1, 2]. For pain, transdermal patches offer consistent release over time [5, 6]. Common side effects across buprenorphine products include nausea, constipation, headache, and drowsiness [1, 5]. Specific side effects and efficacy profiles can vary slightly between brands and dosage forms.
Sources:
[1] https://www.suboxone.com/
[2] https://www.zubsolv.com/
[3] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=process
[4] https://www.drugs.com/subutex.html
[5] https://www.butrans.com/
[6] https://www.buprenex.com/
[7] https://www.drugpatentwatch.com/
[8] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=search